Although the original FDA license for Havrix by GlaxoSmithKline is dated in 1995, it has been in use in Europe since 1993.
Selv om den oprindelige FDA-licens til Havrix af GlaxoSmithKline er dateret i 1995, har den været i brug i Europa siden 1993.